Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Health Catalyst (HCAT) Other Non-Current Liabilities (2018 - 2025)

Health Catalyst (HCAT) has disclosed Other Non-Current Liabilities for 7 consecutive years, with $40000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Other Non-Current Liabilities fell 98.82% year-over-year to $40000.0, compared with a TTM value of $40000.0 through Sep 2025, down 98.82%, and an annual FY2023 reading of $74000.0, down 38.84% over the prior year.
  • Other Non-Current Liabilities was $40000.0 for Q3 2025 at Health Catalyst, down from $2.1 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $14.7 million in Q4 2021 and bottomed at $40000.0 in Q3 2025.
  • Average Other Non-Current Liabilities over 5 years is $2.7 million, with a median of $125000.0 recorded in 2023.
  • The sharpest move saw Other Non-Current Liabilities plummeted 99.18% in 2022, then soared 4550.68% in 2024.
  • Year by year, Other Non-Current Liabilities stood at $14.7 million in 2021, then tumbled by 99.18% to $121000.0 in 2022, then tumbled by 38.84% to $74000.0 in 2023, then surged by 4487.84% to $3.4 million in 2024, then tumbled by 98.82% to $40000.0 in 2025.
  • Business Quant data shows Other Non-Current Liabilities for HCAT at $40000.0 in Q3 2025, $2.1 million in Q2 2025, and $408000.0 in Q1 2025.